Source - SMW
Clinigen Group, the global pharmaceutical and services company, has acquired International Medical Management Corporation, Japan's largest supplier of unlicensed medicines, for an undisclosed sum.

Clinigen said the acquisition would add to its existing footprint in the country following the launch of its Japanese business in October 2016. 

It said the acquisition of IMMC was  part of Clinigen's strategy to become the 'go to' global leader in ethical access to unlicensed medicines and will allow the group to better address unmet patient needs.